NAGIOS: RODERIC FUNCIONANDO

What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies?

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies?

Mostra el registre parcial de l'element

dc.contributor.author Kato, Camila O. es
dc.contributor.author Ribeiro, Michel Campos es
dc.contributor.author Guimaraes Abreu, Mauro Henrique Nogueira es
dc.contributor.author Grossmann, Soraya de Mattos Camargo es
dc.contributor.author Abreu, Lucas G es
dc.contributor.author Caldeira, Patrícia Carlos es
dc.contributor.author Mesquita, Ricardo Alves es
dc.date.accessioned 2021-01-15T09:31:06Z
dc.date.available 2021-01-15T09:31:06Z
dc.date.issued 2020 es
dc.identifier.citation Kato, Camila O. ; Ribeiro, Michel Campos ; Guimaraes Abreu, Mauro Henrique Nogueira ; Grossmann, Soraya de Mattos Camargo ; Abreu, Lucas G ; Caldeira, Patrícia Carlos ; Mesquita, Ricardo Alves. What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies?. En: Medicina oral, patología oral y cirugía bucal. Ed. inglesa, 25 4 2020: 15- es
dc.identifier.uri https://hdl.handle.net/10550/77159
dc.description.abstract This study compared three different concentrations of EO (1.25%, 2.5% and 5%) for the treatment of oral vascular anomalies (OVAs). This was a retrospective comparative analysis of patients with OVAs treated with EO. Anomalies smaller than 20 mm were included. The patients were treated with 1.25% (G1), 2.5% (G2), and 5% (G3) and clinical data were obtained. The number of sessions, the final volume and dose of EO were statistically analyzed to verify effectiveness and safety of the treatment. The different concentrations of EO were compared considering the number of sessions, the final volume and total dose of EO. Analysis of covariance (ANCOVA) was used to evaluate the influence of covariates on the outcomes. A p-value < 0.05 was considered significant. Nineteen women and 11 men with a median age of 54 years were included. The OVAs were most frequent in the lip (n=14) and cheek (n=9). All lesions exhibited complete clinical healing within 28 days. Patients of G3 required fewer sessions than those of G2 (p=0.017), a lower final volume compared to the other groups (p<0.001), and a lower total dose than G1 (p<0.001). Patients of G1 used a lower total dose than G2 (p=0.003). The concentration of 5% EO performed better than 1.25% and 2.5% for sclerotherapy of OVAs measuring up to 20 mm. This preliminary result should be the preferred concentration of EO to provide an effective and safe treatment of OVAs. es
dc.title What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies? es
dc.type journal article es_ES
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.identifier.doi 10.4317/medoral.23448 es
dc.type.hasVersion VoR es_ES

Visualització       (297.4Kb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques